{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:42:43Z","timestamp":1793673763288,"version":"4.5.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EMR\/2016\/001842"],"award-info":[{"award-number":["EMR\/2016\/001842"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cbi.2022.110224","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T23:31:04Z","timestamp":1666222264000},"page":"110224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells"],"prefix":"10.1016","volume":"368","author":[{"given":"Poonam","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanshu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Chetlangia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadharshini","family":"Mayalagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-8947","authenticated-orcid":false,"given":"Devarajan","family":"Karunagaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cbi.2022.110224_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib2","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: a cancer journal for clinicians"},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2022.110224_bib4","series-title":"Colorectal Cancer Facts & Figures 2020-2022","first-page":"48","author":"Society","year":"2020"},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib5","first-page":"101","article-title":"Wnt signaling and colorectal cancer","volume":"13","author":"Schatoff","year":"2017","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"8","key":"10.1016\/j.cbi.2022.110224_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0128-8","article-title":"Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells","volume":"50","author":"He","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.cbi.2022.110224_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nm.4424","article-title":"lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt\/\u03b2-catenin signaling","volume":"23","author":"Lu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2022.110224_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834015614530","article-title":"Pharmacologic resistance in colorectal cancer: a review","volume":"8","author":"Hammond","year":"2016","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3892\/ol.2017.6149","article-title":"BRCA1 expression serves a role in vincristine resistance in colon cancer cells","volume":"14","author":"Xu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"43","key":"10.1016\/j.cbi.2022.110224_bib11","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.3748\/wjg.v21.i43.12234","article-title":"Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer","volume":"21","author":"Fujita","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2022.110224_bib12","article-title":"Natural products for treating colorectal cancer: a mechanistic review","volume":"117","author":"Huang","year":"2019","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.cbi.2022.110224_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1142\/S0192415X17500264","article-title":"Anticancer properties and pharmaceutical applications of plumbagin: a review","volume":"45","author":"Liu","year":"2017","journal-title":"Am. J. Chin. Med."},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.canlet.2013.11.001","article-title":"Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K\/Akt\/mTOR pathway in human non-small cell lung cancer cells","volume":"344","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.cbi.2022.110224_bib15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/ijc.27724","article-title":"Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo","volume":"132","author":"Sinha","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"4b","key":"10.1016\/j.cbi.2022.110224_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1476-5381.2011.01532.x","article-title":"Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2","volume":"165","author":"Lai","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib17","doi-asserted-by":"crossref","first-page":"e18695","DOI":"10.1371\/journal.pone.0018695","article-title":"Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2","volume":"6","author":"Subramaniya","year":"2011","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.cbi.2022.110224_bib18","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1158\/0008-5472.CAN-08-2494","article-title":"Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer","volume":"68","author":"Aziz","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2022.110224_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1476-4598-10-107","article-title":"Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4","volume":"10","author":"Manu","year":"2011","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.cbi.2022.110224_bib20","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3892\/ijo.2014.2592","article-title":"Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis","volume":"45","author":"Eldhose","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.cbi.2022.110224_bib21","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/np4010085","article-title":"Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells","volume":"77","author":"Raghu","year":"2014","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.cbi.2022.110224_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12072-019-09977-w","article-title":"Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma","volume":"14","author":"Huge","year":"2020","journal-title":"Hepatol Int"},{"issue":"12","key":"10.1016\/j.cbi.2022.110224_bib23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ebiom.2015.10.030","article-title":"BCL9\/9L-beta-catenin signaling is associated with poor outcome in colorectal cancer","volume":"2","author":"Moor","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cbi.2022.110224_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104517","article-title":"Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt\/\u03b2-catenin pathway in endocrine resistant breast cancer","volume":"150","author":"Sakunrangsit","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib25","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.3892\/mmr.2017.7222","article-title":"Plumbagin induces apoptosis in human osteosarcoma through ROS generation, endoplasmic reticulum stress and mitochondrial apoptosis pathway","volume":"16","author":"Chao","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.cbi.2022.110224_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1158\/1535-7163.MCT-07-2272","article-title":"Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells","volume":"7","author":"Sun","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1159\/000470815","article-title":"Baicalein, a natural anti-cancer compound, alters MicroRNA expression profiles in bel-7402 human hepatocellular carcinoma cells","volume":"41","author":"Bie","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"176","key":"10.1016\/j.cbi.2022.110224_bib29","article-title":"MicroRNAs associated with colon cancer: new potential prognostic markers and targets for therapy","volume":"8","author":"Zhu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib30","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180212","article-title":"Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis","volume":"9","author":"Chen","year":"2019","journal-title":"Open Biol"},{"issue":"11","key":"10.1016\/j.cbi.2022.110224_bib31","first-page":"1974","article-title":"MiR-29b downregulates canonical Wnt signaling by suppressing coactivators of \u03b2-catenin in human colorectal cancer cells","volume":"115","author":"Subramanian","year":"2014","journal-title":"J. Cell. Biochem."},{"issue":"28","key":"10.1016\/j.cbi.2022.110224_bib32","doi-asserted-by":"crossref","first-page":"44252","DOI":"10.18632\/oncotarget.10020","article-title":"miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer","volume":"7","author":"Xin","year":"2016","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.cbi.2022.110224_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194768","article-title":"Coordination of miR-192 and miR-22 in p53-mediated cell fate decision","volume":"20","author":"Sun","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cbi.2022.110224_bib34","first-page":"5437","article-title":"miR-22-3p suppresses cell proliferation by regulating SP1 in hepatocellular carcinoma","volume":"9","author":"Chen","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"14","key":"10.1016\/j.cbi.2022.110224_bib35","first-page":"2267","article-title":"MiR-22-3p suppresses cell proliferation by targeting AEG-1 in NSCLC","volume":"33","author":"Chang","year":"2017","journal-title":"The Journal of Practical Medicine"},{"issue":"6","key":"10.1016\/j.cbi.2022.110224_bib36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/1873-3468.12603","article-title":"MTA1-activated Epi-microRNA-22 regulates E-cadherin and prostate cancer invasiveness","volume":"591","author":"Dhar","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cbi.2022.110224_bib37","article-title":"Exosomes miR-22-3p derived from mesenchymal stem cells suppress colorectal cancer cell proliferation and invasion by regulating RAP2B and PI3K\/AKT pathway","volume":"2021","author":"Wang","year":"2021","journal-title":"Journal of Oncology"},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib38","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.1080\/21655979.2021.2003942","article-title":"MicroRNA-22-3p targeted regulating transcription factor 7-like 2 (TCF7L2) constrains the Wnt\/beta-catenin pathway and malignant behavior in osteosarcoma","volume":"13","author":"Xue","year":"2022","journal-title":"Bioengineered"},{"issue":"12","key":"10.1016\/j.cbi.2022.110224_bib39","first-page":"5332","article-title":"MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt\/beta-catenin signaling pathway and epithelial-mesenchymal transition","volume":"23","author":"Shi","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.cbi.2022.110224_bib40","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.2337\/db14-1924","article-title":"Elevated hepatic miR-22-3p expression impairs gluconeogenesis by silencing the wnt-responsive transcription factor Tcf7","volume":"64","author":"Kaur","year":"2015","journal-title":"Diabetes"},{"issue":"39","key":"10.1016\/j.cbi.2022.110224_bib41","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1038\/s41388-021-01973-5","article-title":"miR-22 promotes stem cell traits via activating Wnt\/beta-catenin signaling in cutaneous squamous cell carcinoma","volume":"40","author":"Yuan","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1746-4811-3-12","article-title":"Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs","volume":"3","author":"Varkonyi-Gasic","year":"2007","journal-title":"Plant Methods"},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (San Diego, Calif)"},{"issue":"W1","key":"10.1016\/j.cbi.2022.110224_bib44","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118220","article-title":"MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers","volume":"10","author":"Kojima","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib46","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1038\/s41467-018-06434-4","article-title":"Integrated extracellular microRNA profiling for ovarian cancer screening","volume":"9","author":"Yokoi","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cbi.2022.110224_bib47","doi-asserted-by":"crossref","DOI":"10.2196\/27633","article-title":"Web-based survival analysis tool tailored for medical research (KMplot): development and implementation","volume":"23","author":"L\u00e1nczky","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"3","key":"10.1016\/j.cbi.2022.110224_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092444","article-title":"ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays","volume":"9","author":"Guzm\u00e1n","year":"2014","journal-title":"PLoS One"},{"issue":"D1","key":"10.1016\/j.cbi.2022.110224_bib49","doi-asserted-by":"crossref","first-page":"D812","DOI":"10.1093\/nar\/gkw1079","article-title":"dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers","volume":"45","author":"Yang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","article-title":"InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams","volume":"16","author":"Heberle","year":"2015","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib51","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41467-019-08586-3","article-title":"Loss of BCL9\/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer","volume":"10","author":"Gay","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.cbi.2022.110224_bib52","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","article-title":"Serum levels of MicroRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours","volume":"71","author":"Dieckmann","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.cbi.2022.110224_bib54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biopha.2018.11.082","article-title":"Therapeutic potential of targeting the Wnt\/\u03b2-catenin signaling pathway in colorectal cancer","volume":"110","author":"Cheng","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"5307","key":"10.1016\/j.cbi.2022.110224_bib55","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.275.5307.1784","article-title":"Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-\/- colon carcinoma","volume":"275","author":"Korinek","year":"1997","journal-title":"Science (New York, NY)"},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib56","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13402-019-00440-4","article-title":"Inhibition of CBP\/\u03b2-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells","volume":"42","author":"Kleszcz","year":"2019","journal-title":"Cell. Oncol."},{"issue":"9","key":"10.1016\/j.cbi.2022.110224_bib57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/ph14090871","article-title":"Crosstalk of the wnt\/\u03b2-catenin signaling pathway in the induction of apoptosis on cancer cells","volume":"14","author":"Trejo-Solis","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.cbi.2022.110224_bib58","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"10","key":"10.1016\/j.cbi.2022.110224_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102079","article-title":"The role and mechanism of epithelial-to-mesenchymal transition in prostate cancer progression","volume":"18","author":"Lo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"22","key":"10.1016\/j.cbi.2022.110224_bib61","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2217\/fon-2017-0512","article-title":"Regorafenib in the treatment of metastatic colorectal cancer","volume":"14","author":"de la Fouchardiere","year":"2018","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.cbi.2022.110224_bib62","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1758834016635888","article-title":"Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy","volume":"8","author":"Verdaguer","year":"2016","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax5576","article-title":"PRSS contributes to cetuximab resistance in colorectal cancer","volume":"6","author":"Tan","year":"2020","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.cbi.2022.110224_bib64","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jcp.25206","article-title":"Involvement of notch-1 in resistance to regorafenib in colon cancer cells","volume":"231","author":"Mirone","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3892\/or.2020.7869","article-title":"TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562\/G01 cells by neutralizing the Wnt\/betacatenin\/TCF7\/ABC transporter signaling axis","volume":"45","author":"Zhang","year":"2021","journal-title":"Oncol. Rep."},{"issue":"16","key":"10.1016\/j.cbi.2022.110224_bib66","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/pros.23428","article-title":"Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: a pre\u2010clinical study","volume":"77","author":"Abedinpour","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.cbi.2022.110224_bib67","first-page":"4648","article-title":"The effects of plumbagin on pancreatic cancer: a mechanistic network pharmacology approach","volume":"25","author":"Pan","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res.: international medical journal of experimental and clinical research"},{"key":"10.1016\/j.cbi.2022.110224_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2019.103200","article-title":"Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma","volume":"70","author":"Zhou","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2022.110224_bib69","first-page":"1569","article-title":"Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3","volume":"42","author":"Cao","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018695","article-title":"Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2","volume":"6","author":"Subramaniya","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigenet."},{"issue":"6","key":"10.1016\/j.cbi.2022.110224_bib73","doi-asserted-by":"crossref","first-page":"e00410","DOI":"10.1128\/MCB.00410-18","article-title":"A feedback loop between MicroRNA 155 (miR-155), programmed cell death 4, and activation protein 1 modulates the expression of miR-155 and tumorigenesis in tongue cancer","volume":"39","author":"Zargar","year":"2019","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2022.110224_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120268","article-title":"miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells","volume":"291","author":"Sharma","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2022.110224_bib75","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2021.09.033","article-title":"SLC7A11\/xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells","volume":"522","author":"Yadav","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib76","doi-asserted-by":"crossref","first-page":"e1614","DOI":"10.1038\/cddis.2014.556","article-title":"Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer","volume":"6","author":"Vishnubalaji","year":"2015","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cbi.2022.110224_bib77","first-page":"3531","article-title":"Targeting micro-RNAs by natural products: a novel future therapeutic strategy to combat cancer","volume":"12","author":"Alnuqaydan","year":"2020","journal-title":"Am. J. Tourism Res."},{"issue":"10","key":"10.1016\/j.cbi.2022.110224_bib78","first-page":"6381","article-title":"Long noncoding RNA MIR4435-2HG promotes hepatocellular carcinoma proliferation and metastasis through the miR-22-3p\/YWHAZ axis","volume":"12","author":"Shen","year":"2020","journal-title":"Am. J. Tourism Res."},{"issue":"4","key":"10.1016\/j.cbi.2022.110224_bib79","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1096\/fj.201801798RR","article-title":"miR\u201022 and miR\u2010214 targeting BCL9L inhibit proliferation, metastasis, and epithelial\u2010mesenchymal transition by down\u2010regulating Wnt signaling in colon cancer","volume":"33","author":"Sun","year":"2019","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.cbi.2022.110224_bib80","first-page":"1221","article-title":"MiR-22-3p suppresses cell growth via MET\/STAT3 signaling in lung cancer","volume":"13","author":"Yang","year":"2021","journal-title":"Am. J. Tourism Res."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-017-0751-3","article-title":"The Jun\/miR-22\/HuR regulatory axis contributes to tumourigenesis in colorectal cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2022.110224_bib82","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.omtn.2021.01.016","article-title":"ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer","volume":"23","author":"Gorur","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.cbi.2022.110224_bib83","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1007\/s13277-015-4575-8","article-title":"miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1","volume":"37","author":"Chen","year":"2016","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11452","article-title":"miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia","volume":"7","author":"Jiang","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41419-017-0206-1","article-title":"MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1\/Slug\/vimentin feedback loop","volume":"9","author":"Xu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2022.110224_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173227","article-title":"Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: a systematic pharmacology study","volume":"881","author":"Liang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.cbi.2022.110224_bib87","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41419-017-0206-1","article-title":"MiR-22 suppresses epithelial\u2013mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1\/Slug\/vimentin feedback loop","volume":"9","author":"Xu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.cbi.2022.110224_bib88","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.cbi.2022.110224_bib89","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000486773","article-title":"Plumbagin triggers ER stress-mediated apoptosis in prostate cancer cells via induction of ROS","volume":"45","author":"Huang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"10","key":"10.1016\/j.cbi.2022.110224_bib90","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.21873\/anticanres.15287","article-title":"Plumbagin induces cytotoxicity via loss of mitochondrial membrane potential and caspase activation in metastatic retinoblastoma","volume":"41","author":"Gharbaran","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2022.110224_bib91","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.freeradbiomed.2016.05.006","article-title":"Upregulation of microRNA-22 contributes to myocardial ischemia-reperfusion injury by interfering with the mitochondrial function","volume":"96","author":"Du","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2022.110224_bib92","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972200429X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972200429X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:13:50Z","timestamp":1757859230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972200429X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":92,"alternative-id":["S000927972200429X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110224","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110224"}}